Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Evaluation of Drug-Loaded Gold Nanoparticle Cytotoxicity as a Function of Tumor Vasculature-Induced Tissue Heterogeneity.

Miller HA, Frieboes HB.

Ann Biomed Eng. 2019 Jan;47(1):257-271. doi: 10.1007/s10439-018-02146-4. Epub 2018 Oct 8.

PMID:
30298374
2.

An interdisciplinary computational/experimental approach to evaluate drug-loaded gold nanoparticle tumor cytotoxicity.

Curtis LT, England CG, Wu M, Lowengrub J, Frieboes HB.

Nanomedicine (Lond). 2016 Feb;11(3):197-216. doi: 10.2217/nnm.15.195.

3.

Enhanced penetration into 3D cell culture using two and three layered gold nanoparticles.

England CG, Priest T, Zhang G, Sun X, Patel DN, McNally LR, van Berkel V, Gobin AM, Frieboes HB.

Int J Nanomedicine. 2013;8:3603-17. doi: 10.2147/IJN.S51668. Epub 2013 Oct 1.

4.

Two-dimensional chemotherapy simulations demonstrate fundamental transport and tumor response limitations involving nanoparticles.

Sinek J, Frieboes H, Zheng X, Cristini V.

Biomed Microdevices. 2004 Dec;6(4):297-309.

PMID:
15548877
5.

Evaluation of uptake and distribution of gold nanoparticles in solid tumors.

England CG, Gobin AM, Frieboes HB.

Eur Phys J Plus. 2015 Nov 1;130(11). pii: 231. Epub 2015 Nov 19.

6.

Computational Modeling of Tumor Response to Drug Release from Vasculature-Bound Nanoparticles.

Curtis LT, Wu M, Lowengrub J, Decuzzi P, Frieboes HB.

PLoS One. 2015 Dec 14;10(12):e0144888. doi: 10.1371/journal.pone.0144888. eCollection 2015.

7.

The Tumor Microenvironment as a Barrier to Cancer Nanotherapy.

Curtis LT, Frieboes HB.

Adv Exp Med Biol. 2016;936:165-190. Review.

PMID:
27739048
8.

Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin.

Comenge J, Sotelo C, Romero F, Gallego O, Barnadas A, Parada TG, Domínguez F, Puntes VF.

PLoS One. 2012;7(10):e47562. doi: 10.1371/journal.pone.0047562. Epub 2012 Oct 17.

9.

Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors.

Ding D, Zhu Z, Liu Q, Wang J, Hu Y, Jiang X, Liu B.

Eur J Pharm Biopharm. 2011 Sep;79(1):142-9. doi: 10.1016/j.ejpb.2011.01.008. Epub 2011 Jan 25.

PMID:
21272637
10.

Detection of Phosphatidylcholine-Coated Gold Nanoparticles in Orthotopic Pancreatic Adenocarcinoma using Hyperspectral Imaging.

England CG, Huang JS, James KT, Zhang G, Gobin AM, Frieboes HB.

PLoS One. 2015 Jun 5;10(6):e0129172. doi: 10.1371/journal.pone.0129172. eCollection 2015.

11.

Polyaspartic acid functionalized gold nanoparticles for tumor targeted doxorubicin delivery.

Khandekar SV, Kulkarni MG, Devarajan PV.

J Biomed Nanotechnol. 2014 Jan;10(1):143-53.

PMID:
24724506
12.

Cyclodextrin capped gold nanoparticles as a delivery vehicle for a prodrug of cisplatin.

Shi Y, Goodisman J, Dabrowiak JC.

Inorg Chem. 2013 Aug 19;52(16):9418-26. doi: 10.1021/ic400989v. Epub 2013 Jul 29.

PMID:
23889547
13.

Improved efficacy of cisplatin in combination with a nano-formulation of pentacyclic triterpenediol.

Alam N, Qayum A, Kumar A, Khare V, Sharma PR, Andotra SS, Singh SK, Koul S, Gupta PN.

Mater Sci Eng C Mater Biol Appl. 2016 Nov 1;68:109-116. doi: 10.1016/j.msec.2016.05.093. Epub 2016 May 24.

PMID:
27524002
14.

Gold nanoparticle induced vasculature damage in radiotherapy: Comparing protons, megavoltage photons, and kilovoltage photons.

Lin Y, Paganetti H, McMahon SJ, Schuemann J.

Med Phys. 2015 Oct;42(10):5890-902. doi: 10.1118/1.4929975.

15.

Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels.

Zhao X, Pan J, Li W, Yang W, Qin L, Pan Y.

Int J Nanomedicine. 2018 Oct 9;13:6207-6221. doi: 10.2147/IJN.S176928. eCollection 2018.

16.

Xanthan gum stabilized gold nanoparticles: characterization, biocompatibility, stability and cytotoxicity.

Pooja D, Panyaram S, Kulhari H, Rachamalla SS, Sistla R.

Carbohydr Polym. 2014 Sep 22;110:1-9. doi: 10.1016/j.carbpol.2014.03.041. Epub 2014 Mar 28.

PMID:
24906721
17.

Numerical modeling of nanodrug distribution in tumors with heterogeneous vasculature.

Chou CY, Chang WI, Horng TL, Lin WL.

PLoS One. 2017 Dec 29;12(12):e0189802. doi: 10.1371/journal.pone.0189802. eCollection 2017.

18.

Enhanced cytotoxic activity of bile acid cisplatin derivatives by conjugation with gold nanoparticles.

Sánchez-Paradinas S, Pérez-Andrés M, Almendral-Parra MJ, Rodríguez-Fernández E, Millán A, Palacio F, Orfao A, Criado JJ, Fuentes M.

J Inorg Biochem. 2014 Feb;131:8-11. doi: 10.1016/j.jinorgbio.2013.10.021. Epub 2013 Oct 31.

PMID:
24239907
19.

Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin.

Brown SD, Nativo P, Smith JA, Stirling D, Edwards PR, Venugopal B, Flint DJ, Plumb JA, Graham D, Wheate NJ.

J Am Chem Soc. 2010 Apr 7;132(13):4678-84. doi: 10.1021/ja908117a.

20.

Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles.

England CG, Miller MC, Kuttan A, Trent JO, Frieboes HB.

Eur J Pharm Biopharm. 2015 May;92:120-9. doi: 10.1016/j.ejpb.2015.02.017. Epub 2015 Mar 7.

Supplemental Content

Support Center